Inhibition of adipogenesis in 3T3-L1 cells and suppression of abdominal fat accumulation in high-fat diet-feeding C57BL/6J mice after downregulation of hyaluronic acid.
Ji, E; Jung, M Y; Park, J H; Kim, S; Seo, C R; Park, K W; Lee, E K; Yeom, C H; Lee, S.
Int J Obes (Lond)
; 38(8): 1035-43, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24173405
Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model.
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
Vitamin A deficiency suppresses high fructose-induced triglyceride synthesis and elevates resolvin D1 levels.
Exercising the hepatobiliary-gut axis. The impact of physical activity performance.
Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
iPLA2ß deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.